Glioblastoma Clinical Trials in Toulouse
4 recruitingToulouse, France
Showing 1–4 of 4 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Not Applicable
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
Glioblastoma
Institut Claudius Regaud80 enrolled1 locationNCT06222138
Recruiting
Not Applicable
Deciphering Mechanisms Underlying Cancer Immunogenicity
Ovarian CancerCervical CancerHead and Neck Cancer+4 more
Institut Claudius Regaud1,100 enrolled3 locationsNCT03958240
Recruiting
TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Glioblastoma
NovoCure Ltd.430 enrolled24 locationsNCT06924099